Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

CAPS Rating: 3 out of 5

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.

Recs

0
Player Avatar Option1307 (29.88) Submitted: 12/22/2010 9:42:52 PM : Outperform Start Price: $10.00 ALNY Score: +16.37

Portefeuille pick.

Featured Broker Partners


Advertisement